pills twice a day. so you might take 40 pills or so. but it works in terms of reducing the hospitalizations by half. and in the control group, this was 775 patients with -- with sars 2 coronavirus. there were eight deaths in the control, and none in the treatment group. so it's still not a huge study. but it was so compelling that the data safety monitoring board said, stop, we -- this -- this looks like it's really promising, and i think on this basis, merck and company will file for emergency-use authorization. um, it has limits. um, it -- you have to take it very early on in the course of the illness. probably, a day or two after symptoms. u um, you have to know that you are antigen positive so there is going to be some infrastructure that has to be put in place. um, but merck is planning on success and i think they are trying to produce 10 million tablets by the end of the year. the other exciting part of this, don, is unlike vaccines which are very hard to reproduce in scale all over the world. this one is relatively